// App-Quantinova.ai

6580.0 : Upfront DPYD genotyping and toxicity associated with fluoropyrimidine-based concurrent chemoradiotherapy for oropharyngeal carcinomas.

Researchers

Presenter

  • Antoine Desilets

Principal Investigators

  • Francine Aubin

  • Houda Bahig

  • Olivier Ballivy

  • Danielle Charpentier

  • Edith Filion

  • Rahima Jamal

  • Louise Lambert

  • Charles Vadnais

  • Xiaoduan Weng

  • Denis Soulieres

Medical Centers

  • CRCHUM, Montreal, QC, Canada

  • Centre Hospitalier de LUniversite de Montreal (CHUM), Montreal, QC, Canada

  • Centre Hospitalier de LUniversite de Montreal (CHUM), Montreal, QC, Canada

  • Centre Hospitalier de LUniversite de Montreal (CHUM), Montreal, QC, Canada

  • Hopital Notre-Dame, CHUM, Montreal, QC, Canada

  • Centre Hospitalier de LUniversite de Montreal (CHUM), Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Adrucil injection

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A